94434 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitro radicals
Sub-classes:CRYSTALLINE FORMS OF 5-[(2,4-DINITROPHENOXY)METHYL]-1-METHYL-2-NITRO-1H-IMIDAZOLE
#2Preparation Process of 1-N-Methyl-2-Nitro-5-Hydroxymethyl Imidazole
#3DEVICE AND CASSETTE FOR PERFORMING A PLURALITY OF SYNTHESIS PROCESSES OF PREPARING A RADIOPHARMACEUTICAL IN SERIES
#4HYPOXIA-TARGETING CONTRAST AGENT AND METHODS OF USE THEREOF
#5Closed evaporation system
#6Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series
#7Method for producing radiopharmaceutical composition
#8PROCESS FOR PRODUCING FLUORINATED COMPOUNDS USING ALCOHOL SOLVENT HAVING CARBONYL GROUP
#9RENAL IMAGING AGENT
#10Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method
#11RENAL IMAGING AGENT
#12Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride
#13Guanidine compounds and use thereof
#14Production method for producing N-benzyl-2-(2-nitro-1H-imidazol-1-yl) acetamide
#15Method for synthesizing radiopharmaceuticals using a cartridge
#16PRODUCTION OF 18F-LABELLED COMPOUNDS COMPRISING HYDROLYTIC DEPROTECTION STEP AND SOLID PHASE EXTRACTION
#17NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS
#18Method for preparing fluorine-18 eluent with adjusted PH, and method for labelling fluorine-18 using same
#19Radiotracer precursor BANI for imaging of hypoxic tissue, radiotracer, and method for preparing the same
#20Prodrug using nitroimidazole
#21Radioactive fluorine-labeled compound
#22Conjugates of nitroimidazoles and their use as chemotherapeutic agents
#23Cancer targeting using carbonic anhydrase isoform IX inhibitors
#24Di(aminoguanidium) 4,4′,5,5′-tetranitro-2,2′-biimidazole, and preparation method thereof
#25Pharmaceutical composition
#26Pharmaceutical composition
#27Prodrugs containing novel bio-cleavable linkers
#28Prodrugs containing novel bio-cleavable linkers
#29Prodrugs containing novel bio-cleavable linkers
#30Nitric Oxide Releasing Prodrugs of Therapeutic Agents
#31Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
#32PROCESS OF PREPARING A RADIOACTIVE COMPOUND CONTAINING A FLUORINE-18 ISOTOPE
#33Pharmaceutical composition
#34METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS
#35Method for producing 2-nitroimidazole derivative
#36Antineoplastic compounds and pharmaceutical compositions thereof
#37DERIVATIVES OF 2-NITRO-1,3-IMIDAZOLE COUPLED TO AMINO ACIDS AND DEOXYRIBOSE USEFUL FOR THE DETECTION OF HYPOXIC BIOLOGICAL TISSUE
#38Method for preparation of F-18 containing organofluoro compounds in alcohol solvents
#39Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
#40Processes for nitration of N-substituted imidazoles
#41Bioreductively-activated prodrugs
#42Prodrugs containing novel bio-cleavable linkers
#43Preparation of compounds useful for the detection of hypoxia
#44Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#45Prodrugs containing novel bio-cleavable linkers
#46Detection of hypoxia